Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Q&A | August 22, 2022

Principal Vivian Cheng Featured in Law.com Q&A Series "How I Made Partner"

Blog | August 08, 2022

ITC Monthly Wrap-Up: July 2022

Blog | August 04, 2022

Texas Patent Litigation Monthly Wrap-Up: July 2022

Blog | July 18, 2022

Opt-Out from the UPC

Blog | July 18, 2022

Legal Alert: Unitary Patent and UPC Now Projected to Start in Early 2023

Article | July 14, 2022

Fish Attorneys John Pegram and Jan Zecher Author Managing IP Article "Will a UPC Opt-out Survive the Transitional Period?"

Blog | July 11, 2022

ITC Monthly Wrap-Up: June 2022

Article | July 11, 2022

Principal Kelly Del Dotto Interviewed by The Pharma Letter for "Regulatory Q&A: U.S. Patent Law and The Orange Book"

Article | June 23, 2022

Principal Jeremy Saks Authors The National Law Journal Article, "LGBTQ in the Federal Judiciary: A Long Way to Go for Representation"

Blog | June 22, 2022

Legal Alert: Director Vidal Issues Interim Guidance on Discretionary Denials under Fintiv

Article | June 16, 2022

Principal Cynthia Walden and Associate Sarah Kelleher Author World Intellectual Property Review Article "Selling the Intangible in Fashion: What Does It Mean for Trademark Protection?"

Article | June 15, 2022

Attorneys Kenneth Darby and Casey Kraning Author Westlaw Journal IP Article "Prior Art Stipulations, a Petitioner's Tool for Addressing Fintiv Denials"